BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27922981)

  • 1. Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications.
    Grevenkamp F; Kommoss F; Kommoss F; Lax S; Fend F; Wallwiener D; Schönfisch B; Krämer B; Brucker SY; Taran FA; Staebler A; Kommoss S
    Int J Gynecol Cancer; 2017 Feb; 27(2):289-296. PubMed ID: 27922981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
    Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit of Endometrial Cancer Pathology for a Regional Gynecological Oncology Multidisciplinary Meeting.
    Spoor E; Cross P
    Int J Gynecol Pathol; 2019 Nov; 38(6):514-519. PubMed ID: 30252729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies.
    Jacques SM; Qureshi F; Munkarah A; Lawrence WD
    Int J Gynecol Pathol; 1998 Jan; 17(1):36-41. PubMed ID: 9475190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens.
    Jacques SM; Qureshi F; Munkarah A; Lawrence WD
    Int J Gynecol Pathol; 1998 Jan; 17(1):42-5. PubMed ID: 9475191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of low- and intermediate-risk endometrial cancer reports by gynecological pathologists increases risk classification without impacting outcome.
    Alves Pinto de Andrade D; Duval da Silva V; Baiocchi G; de Macedo Matsushita G; Alves de Lima M; Paula Carvalho J; Batista Sandre L; De Brot L; Manuel Reis R; Dos Reis R
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():172-176. PubMed ID: 36208523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
    Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in breast cancer reports after pathology second opinion.
    Marco V; Muntal T; García-Hernandez F; Cortes J; Gonzalez B; Rubio IT
    Breast J; 2014; 20(3):295-301. PubMed ID: 24689830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
    Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.
    Gordetsky J; Collingwood R; Lai WS; Del Carmen Rodriquez Pena M; Rais-Bahrami S
    Int J Surg Pathol; 2018 Feb; 26(1):12-17. PubMed ID: 28905666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.
    Thomas S; Hussein Y; Bandyopadhyay S; Cote M; Hassan O; Abdulfatah E; Alosh B; Guan H; Soslow RA; Ali-Fehmi R
    Arch Pathol Lab Med; 2016 Aug; 140(8):836-43. PubMed ID: 27139150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endometrial carcinoma. Application of the guidelines of 2010: multicentre trial].
    Raimond E; Canlorbe G; Bendifallah S; Hudry D; Selvi F; Ballester M; Coutant C; Graesslin O; Daraï E
    Bull Cancer; 2014; 101(7-8):703-13. PubMed ID: 25091653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specialized histopathological second opinion of advanced ovarian cancer. Experiences with collectives from prospective randomized phase III studies].
    Kommoss S; Pfisterer J; du Bois A; Schmidt D; Kommoss F
    Pathologe; 2014 Jul; 35(4):355-60. PubMed ID: 24992975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement Between Preoperative Endometrial Sampling and Surgical Specimen Findings in Endometrial Carcinoma.
    Garcia TS; Appel M; Rivero R; Kliemann L; Wender MC
    Int J Gynecol Cancer; 2017 Mar; 27(3):473-478. PubMed ID: 28187097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is a pathology review indicated in endometrial cancer?
    Kwon JS; Francis JA; Qiu F; Weir MM; Ettler HC
    Obstet Gynecol; 2007 Dec; 110(6):1224-30. PubMed ID: 18055713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis on timeframes of referral, diagnosis and treatment of patients with endometrial carcinomas in Dunedin Hospital, 2008-2011.
    Kang MY; Sykes P; Herbison PY; Petrich S
    N Z Med J; 2013 Oct; 126(1384):84-95. PubMed ID: 24162633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP).
    Jegatheeswaran K; Cormier B; Dube S; Gotlieb WH; Helpman L; Kwon JS; Lau S; Mah S; May T; Saab D; McNeill M; Plante M; Renaud MC; Shamiya S; Vicus D; Parra-Herran C; Feigenberg T
    Gynecol Oncol; 2020 Oct; 159(1):52-57. PubMed ID: 32694064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
    Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.